aibioARQT Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics (ARQT) news
Top story · Aug 5, 2026 · SEC filing 8-K
Arcutis Biotherapeutics reports a leadership change
(the “Company”) of his decision to resign as chief commercial officer of the Company, effective as of August 21, 2026.
Latest Arcutis Biotherapeutics news
We have not published a story on Arcutis Biotherapeutics yet. When there is news, it will appear here.
Arcutis Biotherapeutics annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $376.1 million | $196.5 million |
| Research and development | $77.1 million | $76.4 million |
| Net income (loss) | -$16.1 million | -$140.0 million |
| Cash from operations | -$5.6 million | -$112.2 million |
| Cash and equivalents | $42.9 million | $71.3 million |
| Short-term investments | $178.1 million | $156.6 million |
Questions about Arcutis Biotherapeutics
What is the ticker symbol of Arcutis Biotherapeutics?
Arcutis Biotherapeutics, Inc. trades under the ticker ARQT on NASDAQ.
Where is Arcutis Biotherapeutics listed?
Arcutis Biotherapeutics, Inc. is listed on NASDAQ.
What is the SEC CIK of Arcutis Biotherapeutics?
The SEC Central Index Key (CIK) for Arcutis Biotherapeutics, Inc. is 1787306. Its filings are on SEC EDGAR.
How many shares does Arcutis Biotherapeutics have outstanding?
125,691,961 shares as of 2026-07-31, per the cover page of its 10-Q filed 2026-08-05.
Which country or territory is Arcutis Biotherapeutics listed under?
Our directory records Arcutis Biotherapeutics, Inc. under United States.
What does Arcutis Biotherapeutics do?
Our directory classifies Arcutis Biotherapeutics, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Arcutis Biotherapeutics?
The ISIN recorded for Arcutis Biotherapeutics, Inc. is US03969K1088.
Does aibio.space cover Arcutis Biotherapeutics?
aibio.space lists Arcutis Biotherapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Arcutis Biotherapeutics incorporated?
SEC records list its state or country of incorporation as DE.
What was Arcutis Biotherapeutics's revenue last year?
$376.1 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Arcutis Biotherapeutics profitable?
Arcutis Biotherapeutics, Inc. reported a net loss of $16.1 million for the fiscal year ended Dec 31, 2025, and used $5.6 million of cash in operations, per its annual report to the SEC.
How much does Arcutis Biotherapeutics spend on research and development?
$77.1 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Arcutis Biotherapeutics have?
$238.6 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
What is Arcutis Biotherapeutics's market cap?
We do not publish live share prices. In its annual report, Arcutis Biotherapeutics, Inc. put the market value of shares held by non-affiliates (public float) at $1.53 billion as of Jun 30, 2025.
Is Arcutis Biotherapeutics a smaller reporting company?
SEC records list Arcutis Biotherapeutics, Inc.'s filer category as: Large accelerated filer.
Investor discussion: Arcutis Biotherapeutics
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
SEC filings and registration
- SEC name
- Arcutis Biotherapeutics, Inc.
- CIK
- 1787306
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- ARQT (Nasdaq)
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- Filer category
- Large accelerated filer
- Business address
- 3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA, 91361
- Phone
- 805-418-5006
- Shares outstanding
- 125,691,961 as of 2026-07-31 (10-Q filed 2026-08-05)
- Former names
- Arcutis, Inc.
Recent filings
Listing details
- Company
- Arcutis Biotherapeutics, Inc.
- Ticker
- ARQT
- Listing
- NASDAQ
- Country or territory
- United States
- Business scope
- Pharmaceuticals: Major
- ISIN
- US03969K1088
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction